These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21534944)

  • 21. Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.
    Kilarski LL; Pearson JP; Newsway V; Majounie E; Knipe MD; Misbahuddin A; Chinnery PF; Burn DJ; Clarke CE; Marion MH; Lewthwaite AJ; Nicholl DJ; Wood NW; Morrison KE; Williams-Gray CH; Evans JR; Sawcer SJ; Barker RA; Wickremaratchi MM; Ben-Shlomo Y; Williams NM; Morris HR
    Mov Disord; 2012 Oct; 27(12):1522-9. PubMed ID: 22956510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation analysis of the parkin and PINK1 genes in American Caucasian early-onset Parkinson disease families.
    Deng H; Le W; Shahed J; Xie W; Jankovic J
    Neurosci Lett; 2008 Jan; 430(1):18-22. PubMed ID: 18068301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage.
    Shadrina MI; Semenova EV; Slominsky PA; Bagyeva GH; Illarioshkin SN; Ivanova-Smolenskaia II; Limborska SA
    BMC Med Genet; 2007 Feb; 8():6. PubMed ID: 17324265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.
    Macedo MG; Verbaan D; Fang Y; van Rooden SM; Visser M; Anar B; Uras A; Groen JL; Rizzu P; van Hilten JJ; Heutink P
    Mov Disord; 2009 Jan; 24(2):196-203. PubMed ID: 18973254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations.
    Deng H; Le WD; Hunter CB; Ondo WG; Guo Y; Xie WJ; Jankovic J
    Arch Neurol; 2006 Feb; 63(2):273-7. PubMed ID: 16476817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic instability in the PARK2 locus is associated with Parkinson's disease.
    Ambroziak W; Koziorowski D; Duszyc K; Górka-Skoczylas P; Potulska-Chromik A; Sławek J; Hoffman-Zacharska D
    J Appl Genet; 2015 Nov; 56(4):451-461. PubMed ID: 25833766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High frequency of Parkin exon rearrangements in Mexican-mestizo patients with early-onset Parkinson's disease.
    Guerrero Camacho JL; Monroy Jaramillo N; Yescas Gómez P; Rodríguez Violante M; Boll Woehrlen C; Alonso Vilatela ME; López López M
    Mov Disord; 2012 Jul; 27(8):1047-51. PubMed ID: 22777964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of deletion mutations in the PARK2 gene in idiopathic Parkinson's disease].
    Slominskiĭ PA; Miloserdova OV; Popova SN; Giliazova IR; Khidiiatova IV; Magzhanov RV; Khusnutdinova EK; Limborskaia SA
    Genetika; 2003 Feb; 39(2):223-8. PubMed ID: 12669418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls.
    Lesage S; Lohmann E; Tison F; Durif F; Dürr A; Brice A;
    J Med Genet; 2008 Jan; 45(1):43-6. PubMed ID: 17766365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkin dosage mutations in patients with early-onset sporadic and familial Parkinson's disease in Chinese: an independent pathogenic role.
    Wang C; Ma H; Feng X; Xie S; Chan P
    Brain Res; 2010 Oct; 1358():30-8. PubMed ID: 20800584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations.
    Hedrich K; Marder K; Harris J; Kann M; Lynch T; Meija-Santana H; Pramstaller PP; Schwinger E; Bressman SB; Fahn S; Klein C
    Neurology; 2002 Apr; 58(8):1239-46. PubMed ID: 11971093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic study of a Parkinson's disease pedigree caused by compound heterozygous mutations in PARK2 gene].
    Chen M; Cen Z; Chen Y; Zheng X; Xie F; Chen S; Luo W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Dec; 35(6):815-818. PubMed ID: 30512153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of exon dosage using MLPA in South African Parkinson's disease patients.
    Keyser RJ; Lombard D; Veikondis R; Carr J; Bardien S
    Neurogenetics; 2010 Jul; 11(3):305-12. PubMed ID: 20013014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low frequency of the PARK2 gene mutations in Polish patients with the early-onset form of Parkinson disease.
    Koziorowski D; Hoffman-Zacharska D; Sławek J; Szirkowiec W; Janik P; Bal J; Friedman A
    Parkinsonism Relat Disord; 2010 Feb; 16(2):136-8. PubMed ID: 19628420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of the parkin and PACRG gene promoter in early-onset parkinsonism.
    Lesage S; Magali P; Lohmann E; Lacomblez L; Teive H; Janin S; Cousin PY; Dürr A; Brice A;
    Hum Mutat; 2007 Jan; 28(1):27-32. PubMed ID: 17068781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel parkin mutations detected in patients with early-onset Parkinson's disease.
    Bertoli-Avella AM; Giroud-Benitez JL; Akyol A; Barbosa E; Schaap O; van der Linde HC; Martignoni E; Lopiano L; Lamberti P; Fincati E; Antonini A; Stocchi F; Montagna P; Squitieri F; Marini P; Abbruzzese G; Fabbrini G; Marconi R; Dalla Libera A; Trianni G; Guidi M; De Gaetano A; Boff Maegawa G; De Leo A; Gallai V; de Rosa G; Vanacore N; Meco G; van Duijn CM; Oostra BA; Heutink P; Bonifati V;
    Mov Disord; 2005 Apr; 20(4):424-431. PubMed ID: 15584030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control.
    Brooks J; Ding J; Simon-Sanchez J; Paisan-Ruiz C; Singleton AB; Scholz SW
    J Med Genet; 2009 Jun; 46(6):375-81. PubMed ID: 19351622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the parkin deletion in sporadic and familial Parkinson's disease. Short communication.
    Krüger R; Vieira-Säcker AM; Kuhn W; Müller T; Woitalla D; Schöls L; Przuntek H; Epplen JT; Riess O
    J Neural Transm (Vienna); 1999; 106(2):159-63. PubMed ID: 10226936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations.
    Camargos ST; Dornas LO; Momeni P; Lees A; Hardy J; Singleton A; Cardoso F
    Mov Disord; 2009 Apr; 24(5):662-6. PubMed ID: 19205068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case-control study of the parkin gene in early-onset Parkinson disease.
    Clark LN; Afridi S; Karlins E; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Arch Neurol; 2006 Apr; 63(4):548-52. PubMed ID: 16606767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.